- Home
- EYEN vs NDRA Comparison
EYEN vs NDRA Comparison
Compare EYEN & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- NDRA
- Stock Information
- Founded
- EYEN 2014
- NDRA 2007
- Country
- EYEN United States
- NDRA United States
- Employees
- EYEN N/A
- NDRA N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- EYEN Health Care
- NDRA Health Care
- Exchange
- EYEN Nasdaq
- NDRA Nasdaq
- Market Cap
- EYEN 2.0M
- NDRA 2.1M
- IPO Year
- EYEN 2018
- NDRA 2017
- Fundamental
- Price
- EYEN $1.09
- NDRA $3.98
- Analyst Decision
- EYEN Hold
- NDRA Strong Buy
- Analyst Count
- EYEN 4
- NDRA 1
- Target Price
- EYEN $2.00
- NDRA $50.00
- AVG Volume (30 Days)
- EYEN 45.2K
- NDRA 355.0K
- Earning Date
- EYEN 04-15-2025
- NDRA 05-13-2025
- Dividend Yield
- EYEN N/A
- NDRA N/A
- EPS Growth
- EYEN N/A
- NDRA N/A
- EPS
- EYEN N/A
- NDRA N/A
- Revenue
- EYEN $57,336.00
- NDRA N/A
- Revenue This Year
- EYEN $7,680.45
- NDRA N/A
- Revenue Next Year
- EYEN $315.38
- NDRA N/A
- P/E Ratio
- EYEN N/A
- NDRA N/A
- Revenue Growth
- EYEN 1414.02
- NDRA N/A
- 52 Week Low
- EYEN $0.85
- NDRA $2.97
- 52 Week High
- EYEN $124.80
- NDRA $665.00
- Technical
- Relative Strength Index (RSI)
- EYEN 39.27
- NDRA 51.65
- Support Level
- EYEN $1.02
- NDRA $3.28
- Resistance Level
- EYEN $1.18
- NDRA $3.98
- Average True Range (ATR)
- EYEN 0.09
- NDRA 0.92
- MACD
- EYEN 0.06
- NDRA 0.02
- Stochastic Oscillator
- EYEN 72.73
- NDRA 31.76
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.